The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Innoviva, Inc(NASDAQ:INVA) 
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma...
Website: http://www.inva.com
Founded: 1996
Full Time Employees: 5
Sector: Healthcare
Industry: Biotechnology
Innoviva Days Payable Outstanding ttm (DPO)
Innoviva Days Receivable Outstanding ttm (DSO)
Innoviva Days Inventory Outstanding ttm (DIO)
Innoviva Op Cashflow Per Share ttm
Innoviva Free Cashflow Per Share ttm
Innoviva Cash Per Share ttm
Innoviva P/S ratio ttm
Innoviva (GAAP) P/E ratio ttm
Innoviva P/B ratio ttm
No extra charts and metrics for this ticker.